These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34890738)

  • 1. ProCaLung - Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium
    Charlier F; Descamps T; Lievens Y; Geets X; Remouchamps V; Lambrecht M; Moretti L
    Radiother Oncol; 2022 Feb; 167():57-64. PubMed ID: 34890738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Peer Review in Reducing Uncertainty in the Definition of the Lung Target Volume Among Trainee Oncologists.
    Mercieca S; Pan S; Belderbos J; Salem A; Tenant S; Aznar MC; Woolf D; Radhakrishna G; van Herk M
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):363-372. PubMed ID: 32033892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.
    Schimek-Jasch T; Troost EG; Rücker G; Prokic V; Avlar M; Duncker-Rohr V; Mix M; Doll C; Grosu AL; Nestle U
    Strahlenther Onkol; 2015 Jun; 191(6):525-33. PubMed ID: 25665799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer.
    Apolle R; Appold S; Bijl HP; Blanchard P; Bussink J; Faivre-Finn C; Khalifa J; Laprie A; Lievens Y; Madani I; Ruffier A; de Ruysscher D; van Elmpt W; Troost EGC
    Acta Oncol; 2019 Oct; 58(10):1378-1385. PubMed ID: 31271079
    [No Abstract]   [Full Text] [Related]  

  • 5. Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.
    Spoelstra FO; Senan S; Le Péchoux C; Ishikura S; Casas F; Ball D; Price A; De Ruysscher D; van Sörnsen de Koste JR;
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1106-13. PubMed ID: 19560881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformal radiotherapy for lung cancer: different delineation of the gross tumor volume (GTV) by radiologists and radiation oncologists.
    Giraud P; Elles S; Helfre S; De Rycke Y; Servois V; Carette MF; Alzieu C; Bondiau PY; Dubray B; Touboul E; Housset M; Rosenwald JC; Cosset JM
    Radiother Oncol; 2002 Jan; 62(1):27-36. PubMed ID: 11830310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU).
    De Hertogh O; Le Bihan G; Zilli T; Palumbo S; Jolicoeur M; Crehange G; Derashodian T; Roubaud G; Salembier C; Supiot S; Chapet O; Achard V; Sargos P
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):29-40. PubMed ID: 37506982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of gross tumor volume in lung cancer: inter-observer variability.
    Van de Steene J; Linthout N; de Mey J; Vinh-Hung V; Claassens C; Noppen M; Bel A; Storme G
    Radiother Oncol; 2002 Jan; 62(1):37-49. PubMed ID: 11830311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of EBUS-TBNA in addition to [
    Guberina M; Darwiche K; Hautzel H; Ploenes T; Pöttgen C; Guberina N; Herrmann K; Umutlu L; Wetter A; Theegarten D; Aigner C; Eberhardt WEE; Schuler M; Karpf-Wissel R; Stuschke M
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2894-2903. PubMed ID: 33547554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective mediastinal node irradiation in non-small cell lung cancer in the IMRT/VMAT era: How to use E(B)US-NA information in addition to PET-CT for delineation?
    Peeters ST; Dooms C; Van Baardwijk A; Dingemans AM; Martinussen H; Vansteenkiste J; Decaluwé H; De Leyn P; Yserbyt J; Nackaerts K; De Wever W; Deroose CM; De Ruysscher D
    Radiother Oncol; 2016 Aug; 120(2):273-8. PubMed ID: 27291644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.
    Vanuytsel LJ; Vansteenkiste JF; Stroobants SG; De Leyn PR; De Wever W; Verbeken EK; Gatti GG; Huyskens DP; Kutcher GJ
    Radiother Oncol; 2000 Jun; 55(3):317-24. PubMed ID: 10869746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified CT-based definition of the supraclavicular and infraclavicular nodal volumes in breast cancer.
    Atean I; Pointreau Y; Ouldamer L; Monghal C; Bougnoux A; Bera G; Barillot I
    Cancer Radiother; 2013 Feb; 17(1):39-43. PubMed ID: 23333457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy.
    Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S
    Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
    Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
    Aznar MC; Girinsky T; Berthelsen AK; Aleman B; Beijert M; Hutchings M; Lievens Y; Meijnders P; Meidahl Petersen P; Schut D; Maraldo MV; van der Maazen R; Specht L
    Acta Oncol; 2017 Apr; 56(4):608-613. PubMed ID: 28105886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
    Senan S; van Sörnsen de Koste J; Samson M; Tankink H; Jansen P; Nowak PJ; Krol AD; Schmitz P; Lagerwaard FJ
    Radiother Oncol; 1999 Dec; 53(3):247-55. PubMed ID: 10660205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in target definition using three different methods to include respiratory motion in radiotherapy of lung cancer.
    Sloth Møller D; Knap MM; Nyeng TB; Khalil AA; Holt MI; Kandi M; Hoffmann L
    Acta Oncol; 2017 Nov; 56(11):1604-1609. PubMed ID: 28885090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.
    Nestle U; Schaefer-Schuler A; Kremp S; Groeschel A; Hellwig D; Rübe C; Kirsch CM
    Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):453-62. PubMed ID: 17058078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Target volume margins for lung cancer: internal target volume/clinical target volume].
    Jouin A; Pourel N
    Cancer Radiother; 2013 Oct; 17(5-6):428-33. PubMed ID: 23988437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.